NCT02429310View on ClinicalTrials.gov

Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Intermittent ClaudicationPeripheral Vascular DiseaseLower Limb Arterial Disease
Interventions
DEVICE

Revitive IX

This is a neuromuscular electrical stimulation device

Trial Locations (1)

W6 8FS

Imperial College London - Charing Cross Hospital, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT02429310 - Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC | Biotech Hunter | Biotech Hunter